Bidders for Sanofi’s consumer healthcare unit are revising their offers in part to address concerns around potential ...

Sanofi plans to spin off its consumer healthcare division, which could be valued at over $16.8 billion. Private equity firms ...

Sanofi says Boehringer's ex-China CHC business is worth an estimated €1.6 billion and is a good fit with its existing business in terms of products and geographies, giving it much increased ...

As Sanofi continues to clean out its medicine chest, Italy’s Recordati is getting in on the action. | Recordati is floating ...

Sanofi has received two separate bids for its consumer health unit, which could be valued at 15 billion euros ($16.74 billion ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions.

Clayton Dubilier & Rice made it a condition for banks to commit more than €1 billion ($1.1 billion) of debt to fund a part of ...

In 2020, Sanofi invested nearly 500 million euros ($554 million) to build what it then called its Evolutive Vaccine Facility (EVF). The idea later evolved into including the manufacture of biologics.

Sanofi Chief Executive Paul Hudson said on Monday that the company has not made a final decision yet on how it plans to split ...

The blockbuster Sanofi and Regeneron Pharmaceuticals drug Dupixent, already commercialized in several skin and lung disorders, has expanded its FDA-approval to chronic obstructive pulmonary ...

CFAO Healthcare expands into South Africa's pharmaceutical market by acquiring Opella Healthcare, enhancing distribution and ...